The Department of Gastroenterology, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
The Department of General Surgery, Jiangning Hospital of Nanjing, Nanjing Medical University, Nanjing, 211100, China.
Surg Endosc. 2019 Dec;33(12):3910-3918. doi: 10.1007/s00464-019-07071-8. Epub 2019 Aug 26.
The role of laparoscopic liver resection (LLR) for lesions located in posterosuperior (PS) segments remains a matter of development to be further assessed. This systematic review aims to compare the short-term and oncological outcomes between laparoscopic and open liver resection (OLR) in PS lesions.
EMBASE, MEDLINE and Cochrane Library were searched from date of inception to June 2019. This meta-analysis was performed using the STATA 12.0 statistical software. Standardized mean differences (SMDs), odds ratios (ORs) and hazard ratios (HRs) were calculated for continuous variables, dichotomous variables and long-term variables, respectively, with 95% confidence intervals (CIs).
A total of 788 patients from eight studies were identified for the final analysis, with 371 patients in the LLR group and 417 in the OLR group. Although the operation time (SMD 0.22; 95% CI 0.08-0.36; P = 0.003) was longer whereas overall complication rate (OR 0.50; 95% CI 0.36-0.70; P < 0.001) and postoperative hospital stay (SMD - 0.45; 95% CI - 0.59 to - 0.30; P = 0.003) were lower in the LLR group than in the OLR group, no significant differences in blood loss (SMD - 0.14; 95% CI - 0.28 to 0.00; P = 0.054), transfusion rate (OR 0.92; 95% CI 0.56-1.54; P = 0.764), major complication rate (OR 0.63; 95% CI 0.38-1.05; P = 0.079), R0 resection rate (OR 1.04; 95% CI 0.55-1.96; P = 0.902), and disease-free survival (DFS) for hepatocellular carcinoma (HCC) (HR 1.43; 95% CI 0.95-2.17), DFS for colorectal liver metastases (HR 1.05; 95% CI 0.61-1.81), overall survival for HCC (HR 1.00; 95% CI 0.43-2.30) were noted between the groups.
LLR is technically feasible and safe without compromising long-term oncological outcomes for selected patients with lesions in the PS segments of the liver.
腹腔镜肝切除术(LLR)在肝后上(PS)段病变中的应用仍有待进一步评估。本系统评价旨在比较 PS 病变腹腔镜与开腹肝切除术(OLR)的短期和肿瘤学结果。
从成立日期到 2019 年 6 月,检索了 EMBASE、MEDLINE 和 Cochrane 图书馆。使用 STATA 12.0 统计软件进行荟萃分析。分别采用标准化均数差(SMD)、比值比(OR)和风险比(HR)对连续变量、二分类变量和长期变量进行计算,置信区间(CI)为 95%。
最终分析共纳入 8 项研究的 788 例患者,其中 LLR 组 371 例,OLR 组 417 例。虽然 LLR 组的手术时间较长(SMD 0.22;95%CI 0.08-0.36;P=0.003),但总并发症发生率(OR 0.50;95%CI 0.36-0.70;P<0.001)和术后住院时间(SMD -0.45;95%CI -0.59 至 -0.30;P=0.003)较低,术中出血量(SMD -0.14;95%CI -0.28 至 0.00;P=0.054)、输血率(OR 0.92;95%CI 0.56-1.54;P=0.764)、主要并发症发生率(OR 0.63;95%CI 0.38-1.05;P=0.079)、R0 切除率(OR 1.04;95%CI 0.55-1.96;P=0.902)、肝细胞癌(HCC)的无病生存率(DFS)(HR 1.43;95%CI 0.95-2.17)、结直肠癌肝转移的 DFS(HR 1.05;95%CI 0.61-1.81)和 HCC 的总生存率(HR 1.00;95%CI 0.43-2.30)在两组之间无显著差异。
对于 PS 段肝脏病变的选定患者,LR 技术上可行且安全,不会影响长期肿瘤学结果。